Commentary

Will CRISPR be safe enough for the clinic?

Read more

A small molecule approach to regenerative medicine

Read more

A new technology for targeting proteins inside cells

Read more

Multi-cytokine profiles inform treatment decisions

Read more

Building a culture of entrepreneurship in Nigeria

Read more

How genome editing is impacting cell therapy

Read more

Building a European capital market

Read more

The new complexity in clinical study protocols

Read more

Why pharma is paying a premium for assets

Read more

Takeovers refocus Sanofi on rare diseases

Read more